$5.00
Today
as of Sep 4, 16:55 ET
Last 30 days
Recent Press Releases & News
TriSalus Life Sciences to Participate in the H.C. Wainwright & Company 28th Annual Global Investment Conference
TriSalus Highlights Tumor-Treatment Expansion, FDA Catalyst at Growth Conference
TriSalus Life Sciences Q2 Earnings Call Highlights
Overview
52-week range
$2.20
$7.95
49% of range
Avg surprise (last 3)
-25.1%
Avg reaction (last 2)
+2.4%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.16 | — | — | — | — | financials |
| Tue May 12, 2026 | Mar/2026 | $-0.14 | $-0.16 | +12.5% | +57.6% | +0.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.96 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.27 | $-0.22 | -22.7% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.33 | $-0.20 | -65.0% | — | +4.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.12 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.21 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.14 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-35.84 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.57 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11M | $9M | — | $12M | $11M | $9M | — | $7M |
| Cost of revenue | $2M | $1M | — | $2M | $2M | $1M | — | $1M |
| Gross profit | $10M | $8M | — | $10M | $9M | $8M | — | $6M |
| Operating income | $-10M | $-8M | — | $-9M | $-7M | $-7M | — | $-9M |
| Net income | $-9M | $2M | — | $-11M | $-8M | $-10M | — | $-2M |
| EPS (diluted) | $-0.16 | $0.03 | — | $-0.96 | $-0.27 | $-0.39 | — | $-0.12 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $46M | $57M | $20M | $23M | $26M | $13M | $9M | $11M |
| Inventory | $4M | $4M | $3M | $3M | $4M | $4M | $4M | $4M |
| Total current assets | $60M | $68M | $32M | $33M | $38M | $25M | $21M | $24M |
| Total assets | $62M | $71M | $35M | $36M | $41M | $29M | $24M | $27M |
| Long-term debt | $33M | $33M | $33M | $33M | $32M | $32M | $22M | $22M |
| Total liabilities | $56M | $58M | $69M | $63M | $61M | $63M | $50M | $48M |
| Total equity | $7M | $13M | $-34M | $-27M | $-19M | $-34M | $-26M | $-20M |
Implied volatility — last 90 days
No IV snapshots yet for TLSI.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.